RRM2B and cancer: Furthermore, FOXO3 and RRM2B inhibited the growth of cancer cells, and in accordance with these results, the IHC results obtained using tissues of human cancer patients indicated that coexpression of FOXO3 and RRM2B is correlated with increased survival and a reduced death rate and cancer recurrence or metastasis in lung-cancer patients.